EMILY PARUCH: Open Payments
NPI 1285231050 · BELLMORE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 21 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $537 · 2025 $550
Food & beverage: $485Education: $65
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $279 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $69 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| CSL Behring | 1 | $35 |
| Lilly USA, LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: DUPIXENT, NEFFY, TEZSPIRE, Andembry, XOLAIR, EBGLYSS, FASENRA, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
